Form 8-K - Current report:
SEC Accession No. 0001493152-26-032387
Filing Date
2026-07-07
Accepted
2026-07-07 17:29:42
Documents
15
Period of Report
2026-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 57345
2 EX-4.1 ex4-1.htm EX-4.1 107665
3 EX-4.2 ex4-2.htm EX-4.2 143518
4 EX-4.3 ex4-3.htm EX-4.3 102825
5 EX-10.1 ex10-1.htm EX-10.1 232677
  Complete submission text file 0001493152-26-032387.txt   936499

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vvos-20260707.xsd EX-101.SCH 3005
7 XBRL LABEL FILE vvos-20260707_lab.xml EX-101.LAB 34239
8 XBRL PRESENTATION FILE vvos-20260707_pre.xml EX-101.PRE 22352
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3339
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 261160272
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)